Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Mark Cuban's Cost Plus Drugs Gets Medication Elon Musk Asked About 6 Months Ago: 'Still Ready To Save Tesla, SpaceX And X a F**kton of Money'

Published 14/12/2023, 08:26
© Reuters.  Mark Cuban's Cost Plus Drugs Gets Medication Elon Musk Asked About 6 Months Ago: 'Still Ready To Save Tesla, SpaceX And X a F**kton of Money'

Benzinga - by Shanthi Rexaline, Benzinga Editor.

Billionaire businessman Mark Cuban, a vocal critic of Elon Musk‘s management of the social-media platform X, responded to Musk’s inquiry about the anti-parasitic treatment, ivermectin.

What happened: A user on the X platform with the handle @MdBreathe questioned Cuban in June about why his Cost Plus Drugs company doesn’t offer ivermectin, highlighting the stark pricing difference between Africa and the U.S. “Why does your company not offer ivermectin? Ivermectin costs $0.02 per pill in Africa, 100x mark-up in America,” the user pointed out.

Cuban’s Cost Plus Drugs company, a public benefit corporation in Dallas, Texas, provides generic drugs at lower prices by eliminating middlemen and using a cost-plus pricing strategy.

Musk interjected, responding to the June post, “Good question.”

In his reply, Cuban explained that his company couldn’t secure a better price than other available sources but offered Hydroxychloroquine instead, a product his company sells.

Cuban also suggested Musk have his employees use Cost Plus Drugs, stating, “It will save them and @twitter a f**kton of money.”

Walks The Talk? About six months later, Cuban updated Musk, sharing a link to purchase Ivermectin on Cost Plus Drugs’ website. He mentioned, “Wanted to let you know we got the med you were asking about.”

“And still available to save @Tesla, @SpaceX, and @X a f**ton of money, just like we have for probably tens of thousands of @X users,” he said, adding, “Just have someone reach out to me.”

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Ashley St. Clair from Babylon Bee commented on Cuban’s post, expressing appreciation and suggesting a lighthearted interview. Ivermectin’s pricing on the Cost Plug Drugs website showed $91.40 for 30 tablets, roughly $3.04 per pill. Comparatively, WebMDRx lists the average cost for 30 tablets of 3mg Stromectol (a branded version of ivermectin) at $188.44 or $6.28 per pill, with a discounted price of $106.85 using the WebMDRx coupon.

The public has raised concerns about drug companies overcharging, alleging that pharmaceutical companies aggressively lobby against legislation aimed at lowering prescription drug costs.

The iShares U.S. Healthcare Providers ETF (NYSE:IHF) ended Wednesday’s session up 1.32% at $265.01, according to Benzinga Pro data.

Read Next: Mark Cuban To Exit Shark Tank: Reflects On His Worst Deal And Surprise Success Shared With Benzinga

Photo: Courtesy of Gage Skidmore on Flickr

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.